METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma
Lina Wang, Qingxia Yang, Qianying Zhou, Fei Fang, Kai Lei, Ziqin Liu, Gaomin Zheng, Lefan Zhu, Jihui Huo, Xiaoxing Li, Sui Peng, Ming Kuang, Shuibin Lin, Manling Huang, Lixia Xu
Topics & Concepts
LenvatinibCancer researchDownregulation and upregulationHepatocellular carcinomaApoptosisCell growthCell cultureIn vivoMedicineOncologyInternal medicineBiologySorafenibGeneBiotechnologyGeneticsBiochemistryRNA modifications and cancerCancer-related gene regulationCancer-related molecular mechanisms research